Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
Via MarketMinute
Topics Artificial Intelligence ETFs
Tickers LLY NVO PFE RHHBY XLV
Exposures Artificial Intelligence Product Safety
News headline image
OrthoPediatrics (KIDS) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers KIDS
Exposures Product Safety
News headline image
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
Via Finterra
Topics Economy
Tickers MRNA NVAX PFE SNY
Exposures COVID-19 Product Safety Supply Chain
News headline image
Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
Via PRLog
Exposures Product Safety
News headline image
Inside the Smucker Surge: A Deep Dive into the Hostess Integration and the $1 Billion Uncrustables Engine
Via Finterra
Topics Earnings Economy World Trade
Tickers BAC GIS GS JPM KHC NSRGY
Exposures COVID-19 Financial Interest Rates
News headline image
NRx Builds Momentum From FDA Progress To Strategic Expansion
Via NewMediaWire
Tickers NRXP
Exposures Product Safety
News headline image
NRx Builds Momentum From FDA Progress To Strategic Expansion
Via TheNewswire.com
Tickers NRXP
Exposures Product Safety
News headline image
Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy ↗
Via Benzinga
Exposures Product Safety
News headline image
Why Did NGNE Stock Surge 25% In Pre-Market Today? ↗
Via Stocktwits
Tickers BBC IWC KOMP NGNE SBIO
Exposures Product Safety
News headline image
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Down 70% Over the Past Year, Can Hims & Hers Health Stock Bounce Back? ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Tickers HIMS
Exposures Financial Intellectual Property Legal
News headline image
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks? ↗
Via Stocktwits
Tickers QURE RGNX RY TSX:RY
Exposures Product Safety
News headline image
Castle Biosciences (CSTL) Earnings Transcript ↗
Via The Motley Fool
Tickers CSTL
Exposures Product Safety
News headline image
Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers LNTH
Exposures Financial Product Safety
News headline image
Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers NTLA
Exposures Financial Product Safety
News headline image
Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths ↗
Via Benzinga
Topics Death
Exposures Death Product Safety
News headline image
Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results
Via MarketMinute
Topics Intellectual Property
Tickers ARM GILD GSK MRK
Exposures Intellectual Property Product Safety
News headline image
Custom vs. Standard LASIK in Portland, Oregon: New Resource from Tersigni Vision Helps Patients Understand Key Differences
Via Press Advantage
Exposures Product Safety
News headline image
FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy ↗
Via Stocktwits
Tickers QURE RGNX
Exposures Product Safety
News headline image
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
Via MarketMinute
Topics Economy Intellectual Property
Tickers AZN BMY LLY MRK NVS PFE
Exposures COVID-19 Intellectual Property Interest Rates
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
Tickers AMZN HIMS LLY NVO
Exposures Financial Intellectual Property Interest Rates
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers BLK LQDA MRK UTHR
Exposures Financial Intellectual Property Interest Rates
News headline image
The Celsius Surge: Why the Market is Re-Energized by CELH’s Adjusted Earnings Beat
Via Finterra
Topics Earnings Economy Lawsuit
Tickers CELH GS MNST MS PEP
Exposures Ethanol Financial Interest Rates
News headline image
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
Via Finterra
Topics Economy
Tickers JPM OGN PFE TEVA UBS VTRS
Exposures Interest Rates Product Safety Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.